Dolby Laboratories Stock News

Dolby Laboratories, Inc. (NYSE:DLB) CEO Kevin J. Yeaman sold 29,457 shares of the company’s stock in a transaction that occurred on Thursday, November 18th. The shares were sold at an average price of $89.79, for a total value of $2,644,944.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which […]

PCRFY vs. DLB: Which Stock Is the Better Value Option?

Parametric Portfolio Associates LLC lifted its stake in Dolby Laboratories, Inc. (NYSE:DLB) by 1.9% during the second quarter, HoldingsChannel.com reports. The firm owned 264,223 shares of the electronics makers stock after purchasing an additional 4,805 shares during the quarter. Parametric Portfolio Associates LLCs holdings in Dolby Laboratories were worth $25,970,000 as of its most recent []

Prudential Financial Inc. boosted its holdings in Dolby Laboratories, Inc. (NYSE:DLB) by 232.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,044 shares of the electronics makers stock after buying an additional 14,019 shares during the period. Prudential Financial Inc.s holdings in []

Windsor Group LTD grew its stake in Dolby Laboratories, Inc. (NYSE:DLB) by 10.1% in the 3rd quarter, Holdings Channel reports. The firm owned 2,295 shares of the electronics makers stock after purchasing an additional 210 shares during the period. Windsor Group LTDs holdings in Dolby Laboratories were worth $204,000 at the end of the most []

Dolby Laboratories (NYSE:DLB) updated its FY22 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $3.52-4.02 for the period, compared to the Thomson Reuters consensus estimate of $3.94. The company issued revenue guidance of $1.34-1.40 billion, compared to the consensus revenue estimate of $1.37 billion.Dolby Laboratories also updated its FY 2022 []

Dolby Laboratories (NYSE:DLB)s stock had its buy rating reiterated by equities researchers at Barrington Research in a research report issued to clients and investors on Thursday, TipRanks reports. They currently have a $114.00 price objective on the electronics makers stock. Barrington Researchs price target would indicate a potential upside of 25.69% from the companys previous []

Dolby Laboratories (NYSE:DLB)s stock had its buy rating restated by equities researchers at Colliers Securities in a research note issued to investors on Wednesday, Zacks.com reports. Separately, Barrington Research upgraded shares of Dolby Laboratories from a market perform rating to an outperform rating and set a $115.00 price target for the company in a report []

Dolby Laboratories (NYSE:DLB) issued an update on its first quarter 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $0.980-$1.130 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.310. The company issued revenue guidance of $345 million-$375 million, compared to the consensus revenue estimate of $389.77 million.Dolby Laboratories []

Dolby Laboratories (NYSE:DLB) updated its first quarter 2022 earnings guidance on Tuesday. The company provided earnings per share guidance of $0.980-$1.130 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.310. The company issued revenue guidance of $345 million-$375 million, compared to the consensus revenue estimate of $389.77 million.Dolby Laboratories []

Dolby Laboratories (NYSE:DLB) issued its quarterly earnings results on Tuesday. The electronics maker reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.02, Briefing.com reports. Dolby Laboratories had a return on equity of 11.41% and a net margin of 23.11%. The firm had revenue of $285.03 million during the []

Accelerated adoption of Dolby Vision and Dolby Atmos technologies help Dolby (DLB) to beat fourth-quarter fiscal 2021 earnings estimates.

Dolby Laboratories, Inc. (DLB) CEO Kevin Yeaman on Q4 2021 Results - Earnings Call Transcript

Dolby Laboratories (NYSE:DLB) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $3.520-$4.020 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.940. The company issued revenue guidance of $1.34 billion-$1.40 billion, compared to the consensus revenue estimate of $1.37 billion.Dolby Laboratories also []